
Release date: 2026-05-27 17:08:02 Article From: Lucius Laos Recommended: 14
During treatment with Tivozanib, some patients may experience fatigue, diarrhea, loss of appetite, nausea, hoarseness, hypothyroidism, cough, and mouth ulcers. For fatigue, it is recommended to balance rest and activity, avoid overexertion, and try light exercises such as short walks to maintain physical strength. For diarrhea, pay attention to fluid and electrolyte replacement to prevent dehydration, and your doctor may prescribe antidiarrheal medication if necessary. For loss of appetite and nausea, try eating small, frequent meals, choose bland, easy-to-digest foods, and avoid greasy or spicy foods. For mouth ulcers, maintain oral hygiene, use a soft-bristled toothbrush, and avoid acidic or very hot foods. For hoarseness, drink plenty of warm water and reduce loud talking. In addition, regular monitoring of blood pressure and thyroid function is very important, as hypertension and hypothyroidism are common side effects that may require medical intervention. Remember, do not stop or reduce the dose on your own due to side effects; instead, inform your doctor promptly for professional evaluation and adjustment.
Although most side effects can be managed, some symptoms require immediate medical help. These include: sudden severe headache, confusion, chest pain, shortness of breath (suggesting hypertensive crisis or heart failure); numbness on one side of the body, difficulty speaking, vision changes (suggesting stroke or blood clot); coughing up blood, vomiting blood, black stools, severe uncontrolled bleeding (suggesting bleeding problems); severe persistent abdominal pain (suggesting gastrointestinal perforation); seizures, vision loss or severe vision changes (suggesting reversible posterior leukoencephalopathy syndrome). For these emergencies, do not wait—contact your doctor immediately or go to the emergency room. Your medical team will determine whether to pause treatment or adjust the dose.
AVEOACE (Access & Excellence Center) is a comprehensive support program specifically designed for patients taking Tivozanib. It provides personalized ongoing assistance, including: understanding your insurance coverage, analyzing out-of-pocket costs for treatment, finding available financial assistance options, providing useful educational resources, and more. Once you and your doctor decide to use Tivozanib, you can enroll in this program. After enrollment, you will have a dedicated ACE program specialist who will guide and support you from pre-treatment insurance verification through every step of your therapy.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:3782025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:5702024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:3592025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:3732025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:3492025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:4202025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:3402025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:3162025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643